Genmab to acquire Merus for USD 97.00 per share in an all-cash transaction representing a transaction value of approximately USD 8.0 billion Proposed acquisition adds petosemtamab, a late-stage asset ...
Genmab to acquire clinical-stage biotechnology company, Merus for USD 8 billion: Copenhagen, Denmark Tuesday, September 30, 2025, 09:00 Hrs [IST] Genmab A/S and Merus N.V. announc ...
The Steam Autumn Sale 2025 is now live and with it you can get lots of games heavily discounted, one of the best times to stock up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback